Literature DB >> 8401945

Block of voltage-dependent sodium currents by the substance P receptor antagonist (+/-)-CP-96,345 in neurones cultured from rat cortex.

M Caeser1, G R Seabrook, J A Kemp.   

Abstract

1. Whole cell patch clamp recordings of voltage- and tetrodotoxin-sensitive Na+ currents were made from cultured rat neocortical neurones (E18). The effects of the non-peptide NK1 receptor antagonist, (+/-)-CP-96,345 on Na+ currents was examined, relative to the effect of the local anaesthetic lignocaine and tetrodotoxin. 2. Sodium currents were reversibly depressed by bath application of (+/-)-CP-96,345 with a half-maximally effective concentration of 18 +/- 2 microM at a stimulation frequency of 0.1 Hz. Likewise the concentrations required to half-maximally inhibit sodium currents by tetrodotoxin and lignocaine were 10 +/- 2 nM and 1.3 +/- 0.2 mM respectively. 3. The depression of sodium currents by (+/-)-CP-96,345 (10 microM) was use-dependent in that raising the stimulus frequency from 0.1 Hz to 10 Hz further decreased the magnitude of sodium currents from 60 +/- 5% to 37 +/- 5% of control values respectively. Similarly, the depression of sodium currents by lignocaine (500 microM) and tetrodotoxin (30 nM) was also accentuated by raising the stimulus frequency from 0.1 Hz to 10 Hz. 4. The effect of (+/-)-CP-96,345 was not associated with a change in either the activation or steady-state inactivation characteristics of these currents, suggesting that its mechanism of action was via open channel blockade. 5. These data demonstrate that in addition to antagonizing NK1 receptors, (+/-)-CP-96,345 also acts as a channel blocker on sodium channels at micromolar concentrations, an effect which should be taken into consideration when examining the antinociceptive or anti-inflammatory action of this compound.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8401945      PMCID: PMC2175733          DOI: 10.1111/j.1476-5381.1993.tb13708.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  51 in total

Review 1.  The structure and function of Na+ channels.

Authors:  W Stühmer; A B Parekh
Journal:  Curr Opin Neurobiol       Date:  1992-06       Impact factor: 6.627

Review 2.  Models of drug interaction with the sodium channel.

Authors:  A O Grant
Journal:  Clin Invest Med       Date:  1991-10       Impact factor: 0.825

3.  An unidentified depressor substance in certain tissue extracts.

Authors:  U S V Euler; J H Gaddum
Journal:  J Physiol       Date:  1931-06-06       Impact factor: 5.182

4.  Voltage-dependent action of tetrodotoxin in mammalian cardiac muscle.

Authors:  M Baer; P M Best; H Reuter
Journal:  Nature       Date:  1976-09-23       Impact factor: 49.962

5.  Structural parts involved in activation and inactivation of the sodium channel.

Authors:  W Stühmer; F Conti; H Suzuki; X D Wang; M Noda; N Yahagi; H Kubo; S Numa
Journal:  Nature       Date:  1989-06-22       Impact factor: 49.962

6.  Sodium channels in dendrites of rat cortical pyramidal neurons.

Authors:  J R Huguenard; O P Hamill; D A Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

7.  Batrachotoxin uncouples gating charge immobilization from fast Na inactivation in squid giant axons.

Authors:  J Tanguy; J Z Yeh
Journal:  Biophys J       Date:  1988-10       Impact factor: 4.033

Review 8.  Block and modulation of cardiac Na+ channels by antiarrhythmic drugs, neurotransmitters and hormones.

Authors:  A O Grant; D J Wendt
Journal:  Trends Pharmacol Sci       Date:  1992-09       Impact factor: 14.819

9.  The sodium current underlying action potentials in guinea pig hippocampal CA1 neurons.

Authors:  P Sah; A J Gibb; P W Gage
Journal:  J Gen Physiol       Date:  1988-03       Impact factor: 4.086

10.  Veratridine modifies open sodium channels.

Authors:  S Barnes; B Hille
Journal:  J Gen Physiol       Date:  1988-03       Impact factor: 4.086

View more
  8 in total

1.  Investigation of the specificity of FK 888 as a tachykinin NK1 receptor antagonist.

Authors:  Z Y Wang; S R Tung; G R Strichartz; R Håkanson
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

2.  Non-specific actions of the non-peptide tachykinin receptor antagonists, CP-96,345, RP 67580 and SR 48968, on neurotransmission.

Authors:  Z Y Wang; S R Tung; G R Strichartz; R Håkanson
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

3.  The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.

Authors:  D T Beattie; I J Beresford; H E Connor; F H Marshall; A B Hawcock; R M Hagan; J Bowers; P J Birch; P Ward
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

4.  Antinociceptive activity of NK1 receptor antagonists: non-specific effects of racemic RP67580.

Authors:  N M Rupniak; S Boyce; A R Williams; G Cook; J Longmore; G R Seabrook; M Caeser; S D Iversen; R G Hill
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

5.  Interdependent regulation of afferent renal nerve activity and renal function: role of transient receptor potential vanilloid type 1, neurokinin 1, and calcitonin gene-related peptide receptors.

Authors:  Chaoqin Xie; Jeffrey R Sachs; Donna H Wang
Journal:  J Pharmacol Exp Ther       Date:  2008-03-25       Impact factor: 4.030

6.  Block of human voltage-sensitive Na+ currents in differentiated SH-SY5Y cells by lifarizine.

Authors:  N A Brown; J A Kemp; G R Seabrook
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

7.  Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.

Authors:  P Picard; D Regoli; R Couture
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

8.  Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord.

Authors:  M Malcangio; N G Bowery
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.